Missing/wrong data?
Log in to edit
Activity and safety of crizotinib in patients with advanced clear-cell sarcoma with MET alterations: European Organization for Research and Treatment of Cancer phase II trial 90101 'CREATE'.
scientific article published on 18 September 2017
Author/s
author: Agnieszka Wozniak, Silvia Stacchiotti, Piotr Rutkowski, Jean-Yves Blay, Sebastian Bauer, Maria Debiec-Rychter
Work details
Publication date
September 18, 2017
-
-
Language
English
Copyright status
Copyright status information is not available for this work. The copyright status depends on the jurisdiction, the author's date of death and the date the work was created or published.
To learn more about copyright terms in different countries, visit the countries and terms page.